title: Is asymptomatic hemorrhagic transformation really innocuous?
authors.forename: Richard B
authors.initials: RB
authors.lastname: Libman
authors.forename: Thomas
authors.initials: T
authors.lastname: Kwiatkowski
authors.forename: Ziad M K
authors.initials: ZM
authors.lastname: El-Zammar
authors.forename: Steven R
authors.initials: SR
authors.lastname: Levine
mesh_terms: D002545:Brain Ischemia / Q000188:drug therapy*; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced*; D008297:Male; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator